About: Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results From New York

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results From New York Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results From New York
Creator	Defrancesco, Chris Dvorzhinskiy, Aleksey Ghahramani, Gregory Goldwyn, Elan Gruskay, Jordan Konnaris, Maxwell Lebrun, Drake Mendias, Christopher Premkumar, Ajay Ricci, William Sandhu, Milan
source	Medline; PMC
abstract	OBJECTIVE: To evaluate inpatient outcomes among patients with hip fracture treated during the COVID-19 pandemic in New York City. DESIGN: Multicenter retrospective cohort study. SETTING: One Level 1 trauma center and one orthopaedic specialty hospital in New York City. PATIENTS/PARTICIPANTS: Fifty-nine consecutive patients (average age 85 years, range: 65–100 years) treated for a hip fracture (OTA/AO 31, 32.1) over a 5-week period, March 20, 2020, to April 24, 2020, during the height of the COVID-19 crisis. MAIN OUTCOME MEASUREMENTS: COVID-19 infection status was used to stratify patients. The primary outcome was inpatient mortality. Secondary outcomes were admission to the intensive care unit, unexpected intubation, pneumonia, deep vein thrombosis, pulmonary embolus, myocardial infarction, cerebrovascular accident, urinary tract infection, and transfusion. Baseline demographics, comorbidities, treatment characteristics, and COVID-related symptomatology were also evaluated. RESULTS: Ten patients (15%) tested positive for COVID-19 (COVID+) (n = 9; 7 preoperatively and 2 postoperatively) or were presumed positive (n = 1), 40 (68%) patients tested negative, and 9 (15%) patients were not tested in the primary hospitalization. American Society of Anesthesiologists' scores were higher in the COVID+ group (d = −0.83; P = 0.04); however, the Charlson Comorbidity Index was similar between the study groups (d = −0.17; P = 0.63). Inpatient mortality was significantly increased in the COVID+ cohort (56% vs. 4%; odds ratio 30.0, 95% confidence interval 4.3–207; P = 0.001). Including the one presumed positive case in the COVID+ cohort increased this difference (60% vs. 2%; odds ratio 72.0, 95% confidence interval 7.9–754; P < 0.001). CONCLUSIONS: Hip fracture patients with concomitant COVID-19 infection had worse American Society of Anesthesiologists' scores but similar baseline comorbidities with significantly higher rates of inpatient mortality compared with those without concomitant COVID-19 infection. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
has issue date	2020-05-27(xsd:dateTime)
bibo:doi	10.1097/bot.0000000000001849
bibo:pmid	32482977
has license	no-cc
sha1sum (hex)	4704f35abc7bb1e6b9d2e8edb187f6921bdae3c8
schema:url	https://doi.org/10.1097/bot.0000000000001849
resource representing a document's title	Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results From New York
has PubMed Central identifier	PMC7302077
has PubMed identifier	32482977
schema:publication	J Orthop Trauma
resource representing a document's body	covid:4704f35abc7bb1e6b9d2e8edb187f6921bdae3c8#body_text
is schema:about of	named entity 'hip fracture' named entity 'COVID-19' named entity 'hip fracture' named entity 'COVID-19 Pandemic' named entity 'hematoma' named entity 'critical care' named entity 'COVID' named entity 'United States' named entity 'pretest' named entity 'intensive care units' named entity 'comorbidities' named entity 'informed consent' named entity 'retrospective cohort study' named entity 'SARS-CoV-2' named entity 'antiviral medications' named entity 'proximal' named entity 'COVID' named entity 'laboratory test' named entity 'odds ratio' named entity 'intubation' named entity 'OTA/AO' named entity 'SARS-CoV-2' named entity 'atrial fibrillation' named entity 'COVID' named entity 'atypical pneumonia' named entity 'inflammation' named entity 'SARS-CoV-2' named entity 'Radiographic' named entity 'COVID' named entity 'Charlson Comorbidity Index' named entity 'asystole' named entity 'laboratory test' named entity 'hip fracture' named entity 'Austria' named entity 'proning' named entity 'infection' named entity 'pacemaker' named entity 'COVID' named entity 'false-negative' named entity 'hip fractures' named entity 'COVID' named entity 'demographic characteristics' named entity 'decubitus ulcer' named entity 'nasal cannula' named entity 'drug-eluting stent' named entity 'COVID' named entity 'respiratory distress' named entity 'nasopharyngeal' named entity 'emergency department' named entity 'asymptomatic' named entity 'hypoxia' named entity 'rRT-PCR' named entity 'hypertension' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'second-hit' named entity 'COVID' named entity 'anosmia' named entity 'COVID' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'infection' named entity 'RT-PCR' named entity 'COVID' named entity 'nausea' named entity 'radiographic' named entity 'COVID-19 pandemic' named entity 'China' named entity 'infection' named entity 'critical care'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software